Arbutus Biopharma Corp (ABUS)
3.63
-0.02
(-0.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.63
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Cash and Short Term Investments (Quarterly): 127.79M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 127.79M |
| June 30, 2024 | 141.99M |
| March 31, 2024 | 129.24M |
| December 31, 2023 | 126.00M |
| September 30, 2023 | 134.18M |
| June 30, 2023 | 152.48M |
| March 31, 2023 | 146.73M |
| December 31, 2022 | 146.91M |
| September 30, 2022 | 134.72M |
| June 30, 2022 | 150.20M |
| March 31, 2022 | 165.48M |
| December 31, 2021 | 155.32M |
| September 30, 2021 | 121.40M |
| June 30, 2021 | 78.38M |
| March 31, 2021 | 131.96M |
| December 31, 2020 | 123.27M |
| September 30, 2020 | 118.30M |
| June 30, 2020 | 82.39M |
| March 31, 2020 | 84.89M |
| December 31, 2019 | 90.83M |
| September 30, 2019 | 90.08M |
| June 30, 2019 | 95.28M |
| March 31, 2019 | 110.59M |
| December 31, 2018 | 124.62M |
| September 30, 2018 | 142.02M |
| Date | Value |
|---|---|
| June 30, 2018 | 154.87M |
| March 31, 2018 | 172.54M |
| December 31, 2017 | 126.35M |
| September 30, 2017 | 88.18M |
| June 30, 2017 | 103.01M |
| March 31, 2017 | 110.38M |
| December 31, 2016 | 130.56M |
| September 30, 2016 | 149.68M |
| June 30, 2016 | 165.31M |
| March 31, 2016 | 172.57M |
| December 31, 2015 | 181.30M |
| September 30, 2015 | 196.10M |
| June 30, 2015 | 207.20M |
| March 31, 2015 | 232.28M |
| December 31, 2014 | 112.16M |
| September 30, 2014 | 108.76M |
| June 30, 2014 | 117.23M |
| March 31, 2014 | 134.36M |
| December 31, 2013 | 68.72M |
| September 30, 2013 | 35.79M |
| June 30, 2013 | 38.72M |
| March 31, 2013 | 43.06M |
| December 31, 2012 | 47.02M |
| September 30, 2012 | 5.723M |
| June 30, 2012 | 6.821M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
78.38M
Minimum
Jun 2021
165.48M
Maximum
Mar 2022
127.12M
Average
130.60M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 930.44M |
| Amicus Therapeutics Inc | 249.76M |
| Ionis Pharmaceuticals Inc | 2.483B |
| GlycoMimetics Inc | 22.39M |
| FibroGen Inc | 140.71M |